strated that in some hereditary angioedema patients The inhibitor of activated fir §t coinponent (Cl-in-with the variant form, both dysfunctional (94%) and hibitor) is the major regidatory factor for the classical functional proteins (6%) are present, and therapy pathway of activation of human complement (l, 2). with androgen derivatives increases both the proteins It has also been shpwn to inhibit several enzymes of (12) , haemostasis: activated Hageman factor (Factor XII), We have used isoelectric focusing to study Cl-inHageman factor fragment, kallikrein, activated hibitor in plasma from normal subjects and in thromboplastin antecedent (Factor XI) and plasmin patients with hereditary angioedema before and dur- (3 -6) . Plasma from patients with" hereditary angio-j n g androgen therapy, to determine the isoelectric edema was found to be deficient in Cl-inhibitor func-point of the protein and evaluate the effects of such tion (inherited äs an autosomal dominant trait), lead-anabolic therapy on the characteristics of Cl-ining to the activation of complement. There are two hibitor. forms of this disease. In the majority of the patients (type l) there are very low levels of antigen concentration (0.026-^0.052 g/l). However 15-20% of the Materials and Methods patients have the variant form with normal (type Ila) Normal and pathological specimens or elevated (type Ilb) antigen concentration of a Blood was drawn into p i ast i c tu b es containing 0.01 mol/1 dysfunctional protein (7) (8) (9) (10) (11) . It has been demon-EDTA. It was centrifuged within l hour, at -h 4°C, and sam-ples were stored in several aliquots at -80 °C until analysed. EDTA-plasma samples were taken from 10 healthy adult volunteers and from 18 hereditary angioedema patients: 10 with type I (Cl-inhibitor antigen level: 0.026-0.052 g/l); 5 with type Ha (Cl-inhibitor antigen level: 0.23 -0.29 g/l) and 3 with type Ilb (Cl-inhibitor antigen level: 0.52-1 g/l).
Cl-inhibitor functional activity was 10-20 U in all 18 patients.
Samples from hereditary angioedema patients were obtained before and during therapy with 400 mg/day Danazol for one month. At the sampling time, all the patients were asymptomatic.
Normal EDTA-plasmas were analysed after 2 hours and after storage for 2-4 month at -80 °C.
Chemicals and antiserum
Acrylamide, N'N'-methylenebisacrylamide and ampholines were obtained from SERVA-Feinbiochemica, Heidelberg (West Germany). The agarose (low-m = 0.13 ± 0.02) was a product of -RAD Laboratories, Richmond Calif. (USA). Specific antisera against Cl-inhibitor and albumin were obtained froin Behringwerke, Marburg (West Germany).
Isoelectric focusing (lEF)-lying on the immunoelectrophoresis matrix Thin layer IEF was performed äs described by Righetti (13) with the following modiflcations: 4.4% polyacrylamide gel was obtained from a stock solution of 30% T 4% C, and contained 1.3 mol/1 glycerol, 3.5% Ampholine 3 -10 and 2.5% Ampholine 2-4; gels were polymerized on glass plates (U frame l mm) with 2.6 mmol/1 tetramethylethylendiamine and 1.7 mmol/1 ammonium persulphate. The anolyte was l .0 mol/1 phosphoric acid and the catholyte l .0 mol/1 sodium hydroxide.
The samples (18 ) were applied to the cathode end side, in a well on the gel surface.
IEF were run on the LKB Multiphore apparatus, with a cooling System (temperature on the gel surface + 6-8 °C), for 4 hours, at 10 W constant power with voltage increasing from 300 to 1600V.
After completion of the isoelectric focusing run, the pH gradient was determined and Strips were cut in the migfation area. They were then placed on 0.9% agarose-4% polyethyleneglycol gel plates containing monospecific antibody, and electrophoresis (3 m A for 12 hours) was performed. Tris/barbital buffer, ionic strengh 0.1, pH 8.6, was used for buffer vessels and gels. Agarose gel plates were stained with Coomassie Brillant Blue.
Cl-inhibitor plasma levels estimation
The antigen level of Cl-inhibitor was determined by single radial immunodiffusion on cellulose acetate Strips (14); Clinhibitor functional activity was determined by its Inhibition of Cl-esterase activity towards N-acetyl-L-tyrosine-ethyl ester (15) .
Cl-inhibitor reference values
Cl-inhibitor antigen level (mean ± SD) = 0.26 ± 0.8 g/l Cl-inhibitor functional activity (mean ± SD) = 0.90 ± 0.12 U of Cl-inhibitor (U of Cl-inhibitor = activity of l ml of fresh normal plasma)
Results
Plasma-EDTA samples from ten normal volunteers were studied by isoelectric focusing-immunoelectrophoresis after 24 hours and after 3 -8 months storage at -80 °C. In all samples, Cl-inhibitor protein focüsed at pH 3.5 -3.6, giving only one peak in immunoelectrophoresis ( fig. 1) Plasma-EDTA samples from ten üntreäted patients with type I hereditary angioedema (Cl-inhibitor antigen level less than 0.052 g/l) gave oiily one peak at pH 3.5 -3.6, äs observed for normal subjects, The same patients were treated with Danazol for one month (400 mg/day). The antigen coiicenträtion of Cl-inhibitor increased to 0.078 -0.10 g/l and functional activity to 35 -45 U. There were no differences between Cl-inhibitor in the plasma-EDTA before and during anabolic therapy ( fig. 2 ).
Of the 8 patients with Type II hereditary angioedema, five (Type Ila) had Cl-inhibitor antigen levels in the ränge 0.21-0.28 g/l and three (Type Ilb) in the ränge 0.52-1 g/l. After one month of therapy with Danazol (400 mg/day), antigen levels had increased about 2 times while functional activity still ranged from 35 to 40 U.
Plasma-EDTA of Type Ha patients gave önly one peak at pH 3.5 -3,6, both before and during Danazol therapy ( fig. 2) .
In 3 üntreäted patients with Type Ilb disease, plasma-EDTA exhibited a minor peak at pH 3.5-3.6, but 80 -90% of the reacting material focüsed at pH 4.5-4.6 ( fig. 3 ). This major peak could not be reproduced when crossed immunoelectrophoresis was performed with an intermediate gel containing*>anti^albumin ( fig.  4) . Although the precisiön öf the quantitative estirnatiön is rather low with this method, Danazol therapy apparently increased equally the amounts of protein focusing at both isoelectric points. angioedema had normal Cl-inhibitor at pH 3.5 -3.6. In type Ha, with normal antigenic levels of Clinhibitor, we could not differentiate functionless protein from normal Cl-inhibitor.
EppendorfDiagnosticasysteme haben \ vieles gemeinsam
In 3 patients (type Ilb) with Cl-inhibitor antigen levels 2-4 times the normal value, the majority of antigenic material was focused at pH 4.5-4.6 and imm noprecipitated both with anti-Cl-inhibitor and anti-albumin, suggesting the presence in the plasma ,of a functionless complex Cl-inhibitor-albumin s previously reported (17) . In all 3 patients, the Clinhibitor in pretreatment plasma was indistinguishable from the Cl-inhibitor obtained during Danazol treatment, which increased the synthesis of both the dysfunctional Cl-inhibitor and normal Cl-inhibitor gene products.
The fact that in type Ha disease both normal and functionless protein have the sanie Charge confirms that the chemical difference responsible for the dysfunetion must be very small (probably a few amino acid substitutions), since it does not cause any detectable change in size or antigenicity.
Discussion
From this study we conclude that Cl-inhibitor is a very acidic protein, with an isoelectric point of 3.5 -3.6, which is intermediate between those previously reported by Haupt (16) and Curd (12) . The Charge on the protein did not change during storage at -80 °C for 8 moaths. All our patients with hereditary 
